HomeCompareAFIF vs JNJ

AFIF vs JNJ: Dividend Comparison 2026

AFIF yields 3.70% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AFIF wins by $5.4K in total portfolio value
10 years
AFIF
AFIF
● Live price
3.70%
Share price
$9.32
Annual div
$0.34
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$468.73
Full AFIF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AFIF vs JNJ

📍 AFIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAFIFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AFIF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AFIF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AFIF
Annual income on $10K today (after 15% tax)
$314.18/yr
After 10yr DRIP, annual income (after tax)
$398.42/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $305.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AFIF + JNJ for your $10,000?

AFIF: 50%JNJ: 50%
100% JNJ50/50100% AFIF
Portfolio after 10yr
$22.7K
Annual income
$648.26/yr
Blended yield
2.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AFIF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AFIF buys
0
JNJ buys
0
No recent congressional trades found for AFIF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAFIFJNJ
Forward yield3.70%3.36%
Annual dividend / share$0.34$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.4K$20.0K
Annual income after 10y$468.73$827.78
Total dividends collected$4.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AFIF vs JNJ ($10,000, DRIP)

YearAFIF PortfolioAFIF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,070$369.62$10,676$355.77+$394.00AFIF
2$12,227$382.39$11,407$389.39+$820.00AFIF
3$13,477$394.73$12,198$426.53+$1.3KAFIF
4$14,828$406.64$13,056$467.62+$1.8KAFIF
5$16,284$418.11$13,987$513.12+$2.3KAFIF
6$17,853$429.13$14,998$563.56+$2.9KAFIF
7$19,542$439.70$16,098$619.52+$3.4KAFIF
8$21,360$449.82$17,295$681.69+$4.1KAFIF
9$23,314$459.49$18,599$750.82+$4.7KAFIF
10$25,415$468.73$20,022$827.78+$5.4KAFIF

AFIF vs JNJ: Complete Analysis 2026

AFIFStock

The fund is an actively managed exchange-traded fund ("ETF") that normally invests at least 80% of its net assets, including any borrowings for investment purposes, in a diversified portfolio of fixed income instruments. The principal investments of the fund include corporate bonds, U.S. government and agency securities, master-limited partners ("MLPs") (tied to energy-related commodities), private debt, foreign sovereign bonds, convertible securities, bank loans, asset-backed securities, mortgage-backed securities, and cash equivalent instruments.

Full AFIF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AFIF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AFIF vs SCHDAFIF vs JEPIAFIF vs OAFIF vs KOAFIF vs MAINAFIF vs ABBVAFIF vs MRKAFIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.